already registered?


register now!
Untitled Document

 

 

You can review the EuroPCR session from TCT 2003 by clicking here.

 

Do SAPPHIRE and ARCHER Establish Carotid Stenting as the Procedure of Choice in All Patients? In High-risk Patients?
 
No—Carotid Endartectomy Remains the Gold Standard Approach for Most Patients!
Orator:
E. B. Diethrich, MD

 

Endovascular Device Approvals and Reimbursement Strategies
 
Physician Perspectives: What Should Determine Carotid Stent Approvals and Reimbursement? 5-minute Presentations
Orator:
E. B. Diethrich, MD

 

Plenary Session 13 Drug-Eluting Stent Euphoria
 
Lessons and “Pearls” From the “Real-world” Drug-Eluting Stent Experience: Evolving Operator Techniques (Tips and Tricks), Adjunctive Pharmacology, and Clinical Indications
Orator:
A. Colombo, MD

 

Point Counterpoint 1: Debates in Coronary Intervention - Real-world Use of Drug-Eluting Stents
 
  Drug-Eluting Stents Should Be Used in Most (or All) Lesions!
Orator:
A. Colombo, MD

 

Top Interventional Trials of the Last Year Drug-Eluting Stent Trials
 
TAXUS-II: A Prospective, Randomized Trial of a Polymerbased Paclitaxel-Eluting Stent in De Novo Coronary Lesions
Orator:
A. Colombo, MD

 

The Drug-Eluting Stent Summit II — The “Proven” Clinical Contenders — Paclitaxel (Polymer-based Delivery)
 
  Subgroup Analyses From TAXUSII (Including 1-year Follow–up)
Orator:
A. Colombo, MD

 

The Drug-Eluting Stent Summit II— Part 1: Live Cases and Clinical Forum - Lesion-specific Drug-Eluting Stent Considerations
 
The Current Status of DES and…Bifurcation Disease 2 (the “Crush Technique” and Beyond)
Orator:
A. Colombo, MD

 

The Drug-Eluting Stent Summit II—Part 2 - Operator Technique Issues, Adjunctive Pharmacology, IVUS, and the Diabetic Patient - The Direct DEStenting Debate
 
  No! Lesion Preparation Improves Precision and Protects the Polymer
Orator:
A. Colombo, MD

 

Global Clinical Perspectives on the Use of Drug-Eluting Stents: A View From Around The World (Mini-Presentations)
 
  EuroPCR: The European Continent
Orator:
J. Marco, MD

 

The "Proven" Clinical Contenders - Sirolimus (Polymer-based Delivery)

 
  Updates From...RAVEL (2-Year Follow-Up)
Orator:
M.-C. Morice, MD

 

Lunchtime Activities - Oral Abstract Presentations 3
 
  Aortic Intervention (Abdominal and Thoracic)
Orator:
A. S. Bortone, MD, PhD